1993
DOI: 10.1016/0190-9622(93)70036-s
|View full text |Cite
|
Sign up to set email alerts
|

Dermatitis in treated maple syrup urine disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0

Year Published

1994
1994
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(26 citation statements)
references
References 7 publications
2
24
0
Order By: Relevance
“…Maple syrup urine disease is an interesting example. Its treatment includes restriction of essential amino‐acids; otherwise the severity of dermatitis worsens with increased control on amino‐acid intake 40–42 …”
Section: Clinical Featuresmentioning
confidence: 99%
“…Maple syrup urine disease is an interesting example. Its treatment includes restriction of essential amino‐acids; otherwise the severity of dermatitis worsens with increased control on amino‐acid intake 40–42 …”
Section: Clinical Featuresmentioning
confidence: 99%
“…A recent case series of 12 patients diagnosed with AD had mixed amino acid deficiencies, notably isoleucine deficiency, with the majority having normal zinc levels (3,5). Our patient was hypoalbuminemic and deficient in several amino acids (not including isoleucine), which was the likely cause of his AD (3).…”
Section: Discussionmentioning
confidence: 71%
“…Our patient developed subnormal plasma-levels of isoleucine and simultaneously eczematous desquamation of the skin on hands, feet and gluteal regions as well as diarrhoea. Dermatitis and gastro-intestinal symptoms have been described in other patients during treatment of MSUD resulting in low plasma levels of isoleucine, leucine, or both (Spraker et al 1986;Giacoia & Berry 1993;Koch et al 1993Koch et al ,1994. Similar symptoms have also been described in patients with arginine deficiency (Goldblum et al 1986) which suggests that this is not an isolated response to any one specific amino acid but rather to several different amino acid deficiency states.…”
Section: Discussionmentioning
confidence: 93%
“…It is characterized by a defect in the branched-chain amino acid decarboxylase with an inability to metabolize the branched amino acids valine, leucine and isoleucine leading to increased levels of these amino acids and their corresponding a-keto acids. Five clinical forms have been described: classic, intermittent, intermediate, thiamineresponsive, and one type associated with pyruvate dehydrogenase complex deficiency (Koch et al 1993). This subclassification is dependent on the re-sidual functional status of the enzyme complex.…”
Section: A P L E Syrup Urine Diseasementioning
confidence: 99%